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Abstract 
Older people are particularly exposed to stressful events, known to activate the Hypothalamus- 
Pituitary-Adrenal axis resulting in increased cortisol levels. High cortisol has been associated 
with deleterious effects on cognition. We hypothesized that stressful life events could increase 
cortisol secretion leading to cognitive impairment. 
A cross-sectional analysis was conducted using data from Colaus/PsyColaus, a longitudinal 
population-based study among Lausanne residents. Salivary cortisol  samples  were  obtained from 
796 non-demented subjects aged at least 65. 
A neuropsychological battery was used to assess cognitive performance and determine  the 
Clinical Dementia Rating Sum Of Boxes (CDRSOB). Lifetime life events  and  their  subjective impact 
were assessed using a validated questionnaire. 
The total impact of life events was associated neither with cortisol AUC nor with CDRSOB nor 
with any cognitive domain performance. The CDRSOB was associated with the cortisol AUC, 
controlling for age, sex, BMI, education, and depressive symptoms (p=0.003; 
B=0.686[0.240;1.333]; r=0.114). This association between CDRSOB and the cortisol AUC 
remained significant after controlling for life events total impact (p=0.040; B=0.591[0.027;1.155]; 
r=0.106). 
These findings do not support the hypothesis that stressful life events increase cortisol secretion 
leading to cognitive impairment. The association of higher cortisol levels with poorer cognition 
might be not a mere reflection of stressful events but rather explained by other factors, yet to 
be elucidated. 
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1. Introduction: 
Older people are particularly exposed to various stressful events. These might be acute (such as 
the death of a relative) or chronic (such as chronic medical conditions or financial difficulties) 
(Comijs, et al., 2011). Moreover, as the age advances, life events (including early and mid-life 
experiences) build up, thus leading to increased stressful life events load. 
Cortisol is known to play a key role in stress. Stressful life events have been shown to activate 
the Hypothalamus-Pituitary-Adrenal (HPA) axis resulting in increased cortisol release (Comijs, et 
al., 2011). 
Cortisol easily crosses the blood–brain barrier and binds to specific receptors throughout the 
brain, in particular in regions involved in cognitive functions (Daskalakis, et al., 2013,McEwen, 
2007,Vogel, et al., 2016). Indeed, the hippocampus, mainly involved in memory, expresses both 
type I (Mineralocorticoid Receptors or MRs) and type II receptors (Glucocorticoid Receptors or 
GRs) and the prefrontal cortex, mainly involved in executive functions, expresses GRs (Lupien, 
et al., 2007,McEwen, 2007). 
Several previous animal as well as clinical studies showed an association between increased 
cortisol and poorer overall cognitive performance (Geerlings, et al., 2015,Lee,  et  al., 2008,Lupien, 
et al., 2007,Tatomir, et al., 2014,Vogel, et al., 2016), declarative memory (Geerlings, et al., 
2015,Lupien, et al., 2007,Tatomir, et al., 2014,Vogel, et al., 2016), language (Lee, et al., 2008), 
processing speed (Lee, et al., 2008), executive functioning (Geerlings, et al., 2015,Lupien, et al., 
2007), spatial memory (de Quervain, et al., 1998) as well as social memory (Takahashi, et al., 
2004). High levels of cortisol have been reported to exhibit neurotoxic effects on the hippocampus 
(Byers and Yaffe, 2011) and have been associated with  hippocampal atrophy (Tatomir, et al., 
2014). At the same time, since the hippocampus regulates the HPA axis activity through an 
inhibitory feed-back loop, hippocampal atrophy associated with elevated cortisol might further 
uninhibit the HPA axis leading to a vicious cascade (Geerlings, et al., 2015). 
Elevated cortisol has also been associated with volume reductions in other regions of the brain 
involved in cognitive functions. Indeed, in a study involving 4244 patients without dementia, 
Geerlings et al. (2015) found that higher evening cortisol was associated with smaller total brain 
volume. Smaller volumes were observed in all brain regions, especially the gray matter 
(Geerlings, et al., 2015). 
Furthermore, glucocorticoids have been shown to exacerbate oxidative injury and amyloid β 
peptide toxicity in cultured hippocampal neurons (Goodman, et al., 1996). High cortisol levels 
have also been  associated with increased amyloid-β peptide and tau pathology in a mouse 
model of Alzheimer's Disease (AD) (Green, et al., 2006). Furthermore, increased Cerebro-Spinal 
Fluid (CSF) cortisol levels have been found in subjects with dementia and Mild Cognitive 
Impairment (MCI) due to AD compared to control subjects with normal cognition (Popp, et al., 
2009,Popp, et al., 2015). In MCI due to AD, high CSF cortisol was also predictive of a more rapid 
cognitive decline (Popp, et al., 2015). 
Studies investigating the possible effects of life events on cognitive performance are relatively 
scarce. Many studies suggested that life events might have negative effects on cognition (Lupien, 
et al., 2007,VonDras, et al., 2005) and might be associated with late-life brain atrophy and white 
matter lesions (Johansson, et al., 2012) as well as with an increased risk of dementia (Johansson, 
et al., 2010,Persson and Skoog, 1996). 
Loss of one’s partner has been associated with cognitive decline. Even though this association 
was reported to be thoroughly explained by depressive symptoms in the study by Ward et al. 
(2007) (Ward, et al., 2007), other studies found that this association was present above and 
beyond depressive symptoms (Aartsen, et al., 2005,van Gelder, et al., 2006,Xavier, et al., 2002). 
However, these links between life events and poorer cognitive performance have not been 
found in other studies (Fountoulakis, et al., 2011,Sundstrom, et al., 2014). Using data from the 
Longitudinal Aging Study Amsterdam, Comijs et al. (2011) reported differential effects of 
different types of life events on cognition: “acute” events were associated with a higher rate of 
cognitive decline whereas “chronic” events were associated with better cognitive function 
(Comijs, et al., 2011). 
 
In the light of these results highlighting that life events were commonly associated with increased 
cortisol, that high cortisol had possible detrimental cognitive effects and that life events 
might lead to cognitive decline, it has commonly been assumed that life events likely impair 
cognition through increased cortisol secretion. However, very few studies actually examined 
these assumed links between life events, cortisol and cognition. 
 
In this study, we hypothesized that life events might increase cortisol secretion leading to cognitive 
impairment, in particular in episodic memory and executive functions. These effects might 
depend on the specific type of life events (acute vs chronic or physical vs social). 
 
2. Methods: 
 
2.1. Participants 
 
A cross-sectional analysis was conducted using data from the first follow-up of the longitudinal 
population-based CoLaus/PsyCoLaus study designed to investigate the prevalence of 
cardiovascular risk factors  and psychiatric disorders in  the community  and  to identify  their 
genetic determinants. The methodological features of this study were already described in detail 
(Firmann, et al., 2008,Preisig, et al., 2009). CoLaus/PsyColaus included a random sample of 6733 
subjects (age range: 35-75 years) selected from the residents of the city of Lausanne 
(Switzerland) between 2003 and 2007. All subjects were also invited to participate at the first 
follow-up, which took place between 2009 and 2013. A total of 5064 and 4004 subjects accepted 
these new physical and psychiatric evaluations which also included salivary cortisol measures. 
In addition, all subjects aged 65 or older (n=1918) were invited to undergo a neuropsychological 
cognitive assessment. CoLaus/PsyCoLaus elicited Information on demographic, medical, and 
treatment history, life events as well as smoking and alcohol consumption using semi-structured 
interviews conducted by trained interviewers or self-rating questionnaires. 
Psychiatric/behavioral disorders were assessed using the Diagnostic Interview for Genetic 
Studies (DIGS) (Preisig, et al., 1999). Cardio-metabolic disorders were assessed clinically and with 
the use of biochemical measures. The distribution of age groups, gender and geographic 
distributions in CoLaus/Psycholaus participants at baseline were similar to  the source population 
(Firmann, et al., 2008). 
 
 
Of the 1918 subjects aged at least 65 at the first follow-up visit of CoLaus/PsyCoLaus, 1214 had 
a thorough cognitive assessment and 796 non-demented (CDR score <1) individuals also agreed 
to provide salivary samples (41.5% of all participants in this age range). 
 
 
 
 
2.2. Cognitive assessment 
 
A neuropsychological and clinical examination as well as an assessment of the participants’ 
daily living activities were performed by trained master-level psychologists blinded for  the salivary 
cortisol and life event scores. 
The neuropsychological assessment included: 
 The assessment of the global cognitive performance using the Mini Mental State 
Examination (MMSE), the most commonly used screening tool for global cognitive 
impairment. MMSE scores range from 0 to 30, a higher score indicating better 
performance. 
 The assessment of memory using the Grober and Buschke Double Memory Test (DMT) 
(Buschke, et al., 1997). 
 The assessment of verbal fluency using the DO40 picture-naming test (Deloche, 1997), 
the letter (phonemic) and the category (semantic) fluency tasks. 
 The assessment of executive functions using the Stroop Test. 
 The assessment of visuo-spatial construction using the figures from the Consortium to 
Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological test battery 
(Morris, et al., 1988). 
All of these tests and scales have been validated and are widely used in the field. 
 
Overall cognitive and functional status was assessed using the CDR scale, a widely used scale for 
the clinical staging of cognitive impairment. The CDR encompasses data about cognitive and 
functional performance in six domains: memory, orientation, judgment and problem solving, 
community affairs, home and hobbies, and personal care (Morris, 1993). 
Participants with a global CDR>=1 (defining dementia) were excluded from the current study. 
The CDR Sum Of Boxes (CDRSOB) was chosen as a main outcome measure. 
 
2.3. Cortisol measures 
 
Salivary cortisol has been established as a reliable indicator of circulating cortisol levels and HPA 
axis function (Gallagher, et al., 2006). Participants used Salivette sampling devices (Sarstedt, 
Rommeldsdorf, Germany) for saliva collection. 
Four salivary samples were obtained from each consenting participant: upon waking, 30 minutes 
after waking, at 11 am and at 8 pm. Subjects were instructed not to brush their teeth and to 
refrain from eating, drinking, smoking and exercising 30 min prior to and during the sampling 
procedure (Kuehner, et al., 2007). Subjects were also instructed to keep a protocol where 
they would record adherence to the protocol including exact time of saliva collections. Until 
sampling had been completed, subjects stored the saliva samples at home in their freezers before 
returning them to the laboratory together with the saliva protocol, where they were stored 
at -20°C until biochemical analysis. 
Free cortisol levels in the salivary samples were measured using a commercially available 
chemiluminescence assay (IBL, Hamburg, Germany). Inter- and intra-assay coefficients of 
variability were <9%. 
In case of non-adherence to the protocol, missing values were analyzed using the expectation- 
maximization algorithm. 
We calculated the cortisol Area Under the Curve (AUC) using the trapezoid formula (Pruessner, 
et al., 2003). 
The AUC is a commonly used measure to estimate total hormonal output over a period of time. 
Unlike other summary measures such as mean cortisol, the AUC captures not only the cortisol 
levels at the times of sampling but also changes over time (Pruessner, et al., 2003). 
We also calculated the Cortisol Awakening Response (CAR) defined as the difference between 
cortisol 30 minutes after waking and cortisol upon waking. 
 
2.4. Life events inventory 
 
Impact of lifetime life events was assessed by the means of the Amiel-Lebigre event 
questionnaire (Amiel-Lebigre, 2004). This validated instrument consists of 52 items covering 
several domains (health, work, finance, interpersonal relationships, family, accidents, deaths, 
finance). For each lifetime event, the participants were instructed to specify the duration as 
well as the perceived negative impact (from 0 to 100, with higher scoring indicating greater 
impacts). 
The total negative impact of life events was calculated by summing up the impact scores of all 
reported events. We also separately calculated the negative impact of acute/chronic and 
“social”/”physical” stressors as we hypothesized that different types of life events might have 
different effects on cognition and cortisol (Comijs, et al., 2011). 
 
2.5. Other variables 
 
Subjective cognitive decline was assessed using the Cognitive Complaint Questionnaire (QPC) 
(Thomas-Antérion, et al., 2003). The QPC is a French-language rater-administered instrument; 
consisting of 10 yes/no questions assessing subjective cognitive changes over the previous six 
months. According to the scoring method proposed by the authors, subjective cognitive decline 
is considered present if the participant gave at least three positive answers to the ten questions 
and/or a positive answer to question 5 and/or at least two positive answers to questions A,4,5,7,8. 
Depressive symptoms were assessed at the same time as the physical evaluation (approximately 
one year before the cognitive assessment) using the Center for  Epidemiologic Studies 
Depression scale (CES-D) in its French version (Morin, et al., 2011). CES-D scores range between 
0 and 60 with higher scores indicating more depressive symptoms. 
Level of formal education was categorized into two groups: primary/secondary   school education 
and higher education. 
Body Mass Index (BMI) was also included as a covariate since cortisol levels might depend on 
BMI (Odeniyi, et al., 2015). 
 
2.6. Ethics 
 
The CoLaus/PsyCoLaus study was approved by the Ethics Committee of the University of 
Lausanne and a written informed consent was obtained from all participants. 
 2.7. Statistical analysis 
 
Statistical analysis was performed using SPSS v23.0 (IBM Corp., Armonk, NY, USA). 
 
Descriptive statistics 
Continuous variables were described as mean±standard deviation, while categorical variables 
were described through absolute and relative frequencies. 
The scores of each cognitive domain (memory, fluency, executive functions and visuo-spatial 
construction) were standardized (z-scores were calculated for the sum of each cognitive domain 
score). 
 
Associations between cognitive performance and cortisol 
Hierarchical multiple linear regression models were constructed with the CDRSOB as an 
outcome variable and with the cortisol AUC then the CAR (respectively) as independent 
variables, controlling for age, sex, BMI, education and CES-D score. 
Afterwards, each cognitive domain z-score was considered as a dependant variable with cortisol 
AUC then CAR (respectively) as independent variables, controlling for age, sex, BMI, education 
and CES-D score. 
 
Associations between cognitive performance and life events 
Hierarchical multiple logistic regression models were constructed with the CDRSOB, then with 
each cognitive domain z-score respectively as dependant variables, and with  the  negative impact 
of life events as an independent variable, controlling for age, sex, BMI, education and CES-D 
score. 
 
Associations between cortisol and life events 
Hierarchical multiple logistic regression models were constructed with the cortisol AUC then 
with the CAR respectively as dependant variables, and with the negative impact of life events as 
an independent variable, controlling for age, sex, BMI, education and CES-D score. 
 
Associations between cognitive performance, cortisol and life events 
A three-block hierarchical multiple regression model was constructed with the CDRSOB as a 
dependant variable. Block one included age, sex, BMI, education and CES-D score. Block two 
included the negative impact of life events score and the interaction between life events and 
the cortisol AUC and block three the cortisol AUC. 
 
For each of these regression models, the unstandardized regression coefficients (B), their 95% 
confidence intervals (CIs), the partial correlation coefficients (r) and the p values are presented. 
For multiple comparisons, p values were adjusted according to Holm-Bonferroni’s method. 
 
3. Results: 
 
3.1. Characteristics of the sample 
 
Compared with the whole PsyCoLaus population aged at least 65 (n=1214), our sub-sample 
(n=796) had a comparable distribution by age, gender, education level, BMI and CES-D score 
(Table 1). 
The results of the different cognitive scores, the life events inventory as well as the cortisol 
 measures are described in Table 2. 
Among the salivary cortisol measures, 207 (6.5% of the total number of values) were missing. 
 
Subjective cognitive decline was not associated with cortisol, cognition, depression or  life events, 
and was not included in further statistical analysis. 
The total impact of life events did not differ between genders and was not associated with the 
CES-D score. Moreover, separating life events into acute/chronic or physical/social did not show 
any significant associations with the CES-D score. 
 
{INSERT Table 1} 
 
{INSERT Table 2} 
 
 
3.2. Life events and cortisol 
 
Neither the cortisol AUC nor the CAR respectively were associated with life events total impact, 
controlling for age, sex, BMI, education and CES-D score. Separating life  events  into acute/chronic 
or physical/social did not modify these results. 
 
3.3. Life events and cognitive performance 
 
Neither the CDRSOB nor the MMSE were associated with life events total impact score, 
controlling for age, sex, BMI, education and depressive symptoms. None of the four cognitive 
domains was associated with life events total impact. Separating life events into acute/chronic 
or physical/social did not modify these results. 
 
3.4. Cognitive performance and cortisol 
 
Global cognitive performance as measured by the CDRSOB was positively associated with the 
cortisol AUC after controlling for age, sex, BMI, education and depressive symptoms (p=0.003; 
B=0.686[0.240;1.333]; r=0.114) (Figure 1). This association remained significant after excluding 
the outliers (the three individuals with the highest cortisol AUC, p=0.006; B=0.684[0.197;1.172]; 
r=0.105). Similarly, the MMSE score was negatively associated with the cortisol AUC, after 
controlling for age, sex, BMI, education and depressive symptoms although the association was 
weaker than with the CDRSOB (p=0.039; B=-1.079[-2.106;-0.052]; r=-0.079). Among the 
cognitive domains, only the memory domain z-score was significantly associated with cortisol 
AUC (p=0.025; B=-0.791[-1.485;-0.098]; r=-0.090). Neither the CDRSOB nor any of the cognitive 
domain z-scores was associated with CAR. 
Among the individual cortisol measures, the 11 am value was significantly associated with the 
CDRSOB, after controlling for age, sex, BMI, education and depressive symptoms (p’=0.012; 
B=1.193[0.397;1.989]; r=0.112). The evening (8 pm) measure was also associated with the 
CDRSOB, but the  association was no longer significant after applying the Holm-Bonferroni’s 
method (Table 3). 
 
{INSERT Table 3} 
 
 3.5. Are  life  events  related  to  the  cortisol  AUC  thereby  affecting  global  cognitive 
performance? 
3.6.  
Global cognitive performance as measured by the CDRSOB remained associated with  the cortisol 
AUC after controlling for life events total impact and for the interaction between life events 
and cortisol AUC (p=0.002; B=0.694[0.248;1.141]; r=0.116) (Figure 1). 
This association between the CDRSOB and the cortisol AUC also remained after controlling for 
the negative impact of events subdivided into acute/chronic or physical/social and the 
interaction between the cortisol AUC and the negative impact of respectively acute/chronic, 
physical/social life events. 
 
{INSERT Figure 1} 
 
 
4. Discussion: 
In this study, we analyzed the relationships between life events, cortisol levels and cognitive 
performance in a large sample of non-demented subjects aged >=65 years from the general 
population. We found that the subjectively rated total impact of life events was not associated 
with a poorer cognitive performance. In contrast, higher cortisol levels were associated with 
poorer global cognitive performance and more particularly with poorer episodic memory, 
regardless of life events. 
 
4.1. Life events and cortisol 
 
In our study, cortisol was not associated with the life events score, regardless of whether a 
lifetime score or scores distinguishing between acute/chronic or physical/social events were 
used. While it has been previously assumed that stressful life events are associated with increased 
cortisol, the link between life events and the HPA axis appears to be much more complex 
and still need to be elucidated. Stressful events have been shown to be associated with 
increased cortisol levels in some studies but with decreased cortisol levels in others (Daskalakis, 
et al., 2013,Miller, et al., 2007). It has been suggested that the effect of stressful events on 
the HPA axis might depend on several factors, including the nature of the stressor, the time 
elapsed since its onset, its controllability, the core emotions it is likely to elicit as well as its 
psychiatric sequelae (Miller, et al., 2007). Hence, while “social stressors” have been more 
commonly associated with increased cortisol, “physical” and traumatizing stressors have been 
rather associated with lower cortisol. Moreover, while a given stressor might acutely activate 
the HPA axis, cortisol levels tend  to decrease with time,  eventually  reaching  below-normal levels 
(Miller, et al., 2007). In our study, separating life events into acute/chronic or physical/social 
categories did not show any association between cortisol and the impact of any of these 
categories. The complexity of the link between life events and the HPA axis and the likely role 
of many other factors might explain this finding. 
Moreover, although repeated exposure to stressors may disrupt the HPA axis (allostatic load), 
this does not necessarily occur in all individuals. Some individuals are indeed resilient and are 
able to adapt to adversity, likely through a better adaptation of their HPA axis functioning, 
  
among other mechanisms (Garrido, 2011). Different coping styles may lead to different 
neuroendocrine responses, and thus to different vulnerabilities to stress-mediated disease 
(Koolhaas, et al., 1999). 
This goes in line with the fact that we did not find, in our study, any link between depressive 
symptoms and the negative impact of all, acute/chronic or physical/social life events. Indeed, 
depression has been commonly associated with life events, in particular chronic and social ones 
(Miller, et al., 2007). The time elapsed since the occurrence of the life event, a variable which is 
not captured by our questionnaire, might explain these results. 
 
4.2. Life events and cognitive performance 
 
In our study, neither the global cognitive performance nor any cognitive subdomain score was 
associated with the life events score. Results of similar studies so far have been conflicting. 
Indeed, many studies reported that stressful events were associated with poorer cognitive 
performance, mainly affecting memory and/or executive  functions (Lupien, et al., 2007,van 
Gelder, et al., 2006,VonDras, et al., 2005,Xavier, et al., 2002), and with an increased risk of late- 
life dementia (Johansson, et al., 2010), late-life brain atrophy and white matter lesions 
(Johansson, et al., 2012). Yet, other studies did not find any link between life events  and cognition 
(Fountoulakis, et al., 2011,Sundstrom, et al., 2014,Ward, et al., 2007) and some even reported a 
possibly enhanced cognitive functioning following stressful events  (Deeg,  et  al., 2005). 
These differences might be due to methodological variance across studies, including the sample 
selection, the assessed type of life events and the inclusion of potential confounders in the 
statistical models such as depression, prior cognitive impairment or genetic predisposition. 
Indeed, life events have widely been associated with depression and given that some studies 
did not control for depressive symptoms, it remains unclear whether life events are actually 
associated with cognitive impairment beyond the effects attributable to depression (Comijs, et 
al., 2011). In our study, life events were not associated with cognitive impairment after 
controlling for different possible confounders including depressive symptoms. Moreover, the 
effects of life events might differ depending on the presence of prior cognitive impairment. 
Indeed, Peavy et al. (2009) reported that higher event-based stress ratings were associated 
with faster cognitive decline in subjects with MCI but not in cognitively intact individuals (Peavy, 
et al., 2009). 
Different life events might also display different cognitive effects. Rosnick et al. (2007) found 
that experiencing the injury or illness of a friend was associated with better performance on 
recall, psychomotor speed and attention tasks. Yet, having less money to live on and being 
victim of a crime were associated with poorer performance on psychomotor speed tasks (Rosnick, 
et al., 2007). Comijs et al. (2011) found that acute stressors, such as the death of a (grand)child, 
were associated with a faster cognitive decline, whereas chronic stressors, such as the illness of 
a partner or relative, were associated with a slower cognitive decline (Comijs, et al., 2011). 
Fountoulakis et al. (2011) found that the association between life events and cognition might 
be falsely positive due to the inclusion of events that are causally related to dementia or 
secondarily related to the disease (Fountoulakis, et al., 2011 ). 
Given the complexity of the inter-relationships between life events and cognition, our negative 
results should probably not dismiss the possible effects of cumulative stress on the cognitive 
performance in older age. 
 
4.3. Cognitive performance and cortisol 
  
The link found between higher cortisol levels and poorer cognitive performance is consistent 
with many previous studies. Indeed, most studies which focused on the link between cortisol 
levels and cognition in the older individuals without dementia found a negative association 
(Geerlings, et al., 2015,Lara, et al., 2015,Lee, et al., 2008,Li, et al., 2006,Lupien, et al., 1994). 
Similarly, increased cortisol levels were found in association  with  more  rapid  disease progression 
in subjects with very mild or mild AD dementia (Csernansky, et al., 2006), and in MCI due to 
AD (Popp, et al., 2015). Altered cortisol suppression after dexamethasone (DXT) administration, 
has also been described in AD. The prevalence of DXT non-suppressors among AD patients has 
been reported to range between 30% and 50%, with higher prevalences in the most cognitively 
affected patients (Murialdo, et al., 2000). 
Yet, other studies reported opposite results with increased salivary cortisol being associated 
with a slower cognitive decline in individuals with MCI (Peavy, et al., 2009) and with better 
explicit memory in postmenopausal women using  hormone replacement therapy  (Hampson and 
Duff-Canning, 2016). 
This discrepancy might be explained by different designs but also by different effects of cortisol 
on cognitive performance depending on its levels in the brain. This has been hypothesized to be 
due to differential effects of MRs and GRs. Thus, activation of MRs seems to enhance memory 
while activation of GRs seems to impair memory. MRs have a ten-fold higher affinity for cortisol 
so that mildly elevated cortisol levels mainly activate MRs in the hippocampus, thus resulting in 
enhancing effects. Higher levels result in an activation of both MRs and GRs in the hippocampus 
explaining the deleterious effects on declarative memory (Lupien, et al., 2007). This is 
consistent with the results of several previous animal as well as clinical studies showing that the 
effects of cortisol on declarative memory could be described by an inverted-U plot (de Kloet, et 
al., 1999,Lupien, et al., 2007,McEwen, 2007). 
In the prefrontal cortex, where only GRs are expressed, elevated cortisol displays clearer 
detrimental effects on executive functions (Lupien, et al., 2007,McEwen, 2007). 
In some cases, the link between cortisol and cognition may be accounted for by residual 
depressive symptoms. Indeed, depression may be associated with increased cortisol secretion 
and reduced feedback sensitivity of the HPA axis. In addition, depression  commonly encompasses 
cognitive deficits (Wingenfeld and Wolf, 2015). In our study, since we controlled for the CES-D 
score, the link between cortisol and cognition seems to be independent of depressive symptoms. 
Previous studies reported the association between evening cortisol levels and worse performance 
in delayed paragraph recall (Li, et al., 2006), worse performance across all cognitive domains 
and smaller brain volumes (Geerlings, et al., 2015) in non-demented older subjects. In our 
study, the evening measure was also associated with the CDRSOB, but the association was 
no longer significant after the Holm-Bonferroni’s correction. Rather, we found that the measure 
at 11 am was significantly associated with the CDRSOB. Since the 11am and the 8pm measures 
are the ones with the most important influence on the cortisol AUC, our results suggest that 
poorer cognition is likely to be associated with an overall increased cortisol secretion pattern 
rather than a specific change in the circadian rhythm. 
 
Additionally, we did not find any link between the CAR and the cognitive performance. This 
contrasts with the findings of Hidalgo et al. who found that the CAR was negatively related to 
verbal and visual memory domains (Hidalgo, et al., 2016). This discrepancy might be due to the 
fact that the authors used three measures per day on two consecutive days to calculate the 
CAR, which may have provided a more accurate capture of the CAR (Hidalgo, et al., 2016). 
 
 4.4. Are life events related to the cortisol AUC thereby affecting global cognitive 
performance? 
 
It has often been assumed that “stress” and “stressful events” might explain increased cortisol 
levels, eventually leading to impaired cognition (Lupien, et al., 2007,McEwen, 2007). Life events 
impact score was associated neither with cortisol nor with cognition. However, we observed 
that cortisol was associated with poorer cognitive performance independently of life events. 
There are several potential explanations for the lack of an association between life events and 
cortisol levels or  poor  cognitive functioning. First, the direction  of the association  between 
cortisol and poor cognitive functioning could be inverse: since the hippocampus inhibits the 
HPA axis, the observed high cortisol levels could be due to the hippocampal atrophy itself, with 
cortisol gradually increasing as the  hippocampal atrophy advances (Geerlings, et al., 2015). 
Second, although cortisol is often referred to as the stress hormone (Lupien, et al., 2007) a 
series of other factors than life events determine its secretion, including metabolic and immune 
factors. 
The established association between elevated cortisol and poorer cognitive functioning does 
not need to be direct. Given that cortisol plays a key role in metabolism it has been shown to be 
associated with the metabolic syndrome and insulin resistance, which, in turn, are tightly linked 
to vascular dementia and AD (Kim and Feldman, 2015). 
 
4.5. Strengths and limitations 
 
Major strengths of this study include its population-based design and the large sample size for 
this type of studies. Other strengths include the detailed neuropsychological examination. 
Moreover, in comparison with most other studies, we used an extensive life events inventory 
with a subjective rating of the impact of each event by the participant. We also controlled for a 
number of other potential confounders. 
Nevertheless, some limitations are to be acknowledged. First, the cross-sectional design does 
not allow us to draw any conclusions about cause-to-effect relationships. Second, only 41.5% of 
the participants of 65 years and older underwent both the cognitive evaluation and the cortisol 
assessment. Nevertheless, it is not likely that  selection  bias  significantly  affected  the established 
associations between cortisol or life events and cognitive functioning. Third, all participants were 
residents of an urban area in Switzerland, which reduces the generalizabity of the findings. Fourth, 
the cortisol measure was restricted to one day, which limits the accuracy of this assessment. 
There were four salivary cortisol time points. Hence a single spurious measurement deviating 
from the circadian rhythm could have biased the cortisol AUC. The use of the trapezoid formula 
to calculate the cortisol AUC may have underestimated the true value of cortisol output between 
11am and 8pm. Nevertheless, most previous population-based studies had only one cortisol 
measure. Our cortisol measures were also static. Fifth, the CAR measures relied on two post-
awakening samples, a protocol used in most population-based studies, providing a general 
approximation of the CAR. However, in some individuals, more samples might be needed to 
be sure to capture the CAR peak (Hidalgo, et al., 2016,Stalder, et al., 2016). 
 
 
 
5. Conclusions: 
 
In this population-based study, we found that elevated cortisol was associated with poorer 
 cognitive performance, in particular with poorer memory performance, independently of life 
events. We did not find a link between life events and both cortisol measures and global cognitive 
performance. Accordingly, the association between increased cortisol levels and poor cognition 
was independent of stressful life events. Thus, the link between life events and the HPA axis is 
likely to be much more complex than life events simply activating cortisol secretion. Increased 
cortisol levels may be not only a factor contributing to cognitive impairment but may also reflect 
damage and dysfunction of the brain structures related to both the HPA axis andcognitive 
performance. Longitudinal follow-up studies are necessary to better understand the complex 
interplay between life events, cortisol, and cognition. 
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Annexes  
 
 
 
Table 1: General characteristics of the studied population 
 
 
 PsyCoLaus  Studied  p 
 population aged  population 
 at least 65 
n                                                                                                      1214                               796 
Age, years (m ±SD)                                                                      71.6±4.7                         71.5±4.6                  0.51 
Gender, % women                                                                      57.9                                58.3                          0.80 
Education level, % higher education                                      40.5                                 38.8                           0.27 
BMI, Kg/m2 (m ±SD)                                                                    26.9±4.7                         26.8±4.6                  0.51 
CES-D score (m ±SD)                                                                    10.3±8.2                         10.1±7.9                  0.45 
 
m: Mean ; SD: Standard Deviation; BMI : Body Mass Index ; CES-D: Center for Epidemiologic Studies Depression scale 
 
 
  
 Table 2: Cognitive and cortisol profile of the studied population 
 
CDRSOB (m ±SD) 0.9±0.7 
CDR score,  n(%) 
 0^ 379 (47.6) 
 0.5 417(52.4) 
QPC, subjective cognitive decline present, n(%) 53(21.9) 
MMSE score (0-30) (m ±SD)  29.2±1.6 
DMT (m ±SD) 
 Immediate recall (0-16)  15.8±1.1 
 Total free recall (0-48)  29.8±6.9 
 Total cued recall (0-48)  18.0±9.2 
 Identification (0-16) 15.9±0.4 
 Recognition (0-48)  44.8±9.4 
 Delayed free recall (0-16)  11.6±2.6 
 Delayed cued recall (0-16) 4.9±3.7 
 
DO40 picture-naming test (0-40) (m ±SD) 39.7±1.2 
Semantic verbal fluency (m ±SD) 29.5±8.1 
Phonemic verbal fluency (m ±SD) 20.9±7.8 
Stroop test (m ±SD) 
 Stroop dots condition (0-24) 23.9±0.6 
 Stroop words condition (0-24) 23.9±0.4 
 Stroop interference condition (0-24) 23.2±1.9 
 
CERAD figures (0-11) (m ±SD) 10.5±1.0 
Life events 
Number of life events (m ±SD) 7.9±4.8 
Mean impact (0-100) (m ±SD) 27.5±14.2 
 
Cortisol AUC, in µmol.h/L (m ±SD) 0.28±0.11 
CAR, in nmol/L (m ±SD)  6.7±12.1 
m: Mean ; SD: Standard Deviation; CDR: Clinical Dementia Rating; CDRSOB: Clinical Dementia Rating Sum Of Boxes; QPC: Cognitive 
Complaint Questionnaire; MMSE: Mini Mental State Examination; DMT: Grober and Buschke Double Memory Test; DO40: CERAD: 
Consortium to Establish a Registry for Alzheimer's Disease; 
AUC : Area Under the Curve; CAR: Cortisol Awakening Response 
 
 
  
 Table 3: Associations between the CDR Sum Of Boxes and the individual cortisol measures 
 
 
Cortisol measure B[95% CI] r p p ‘ 
Waking 0.937[ -0.119;1.992] 0.066 0.082 0.164 
30 minutes after waking 0.458[ -0.931;1.846] 0.025 0.518 0.518 
11 am 1.193[0.397;1.989] 0.112 0.003 0.012* 
8 pm 0.533[0.036;1.030] 0.080 0.036 0.108 
 
p’ corresponds to the p value after adjustment for multiple comparisons using the Holm-Bonferroni’s method 
* p’<=0.05 
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Figure 1: Scatter plot graphs of partial regression analysis results for the association between the CDR 
Sum Of Boxes and Cortisol AUC before (a) and after (b) controlling for life events total impact and for 
the interaction between life events and cortisol AUC* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Associations are adjusted for age, sex, education, BMI and depressive symptoms 
AUC: Area Under the Curve; CDR: Clinical Dementia Rating scale 
 
  
 
